HPV16L1-attenuated Shigella recombinant vaccine induced strong vaginal and systemic immune responses in guinea pig model

Fusion of HPV L1 into Shigella surface IcsA: A new approach in developing live attenuated Shigella-HPV vaccine

(2013) Dan Xu et al.   ANTIVIRAL RESEARCH

Intranasal Vaccination with AAV5 and 9 Vectors Against Human Papillomavirus Type 16 in Rhesus Macaques

(2012) Karen Nieto et al.   HUMAN GENE THERAPY

HPV vaccine continues to be safe and effective, and its benefits continue to outweigh its risks

(2010) Richard M Haupt et al.   Expert Review of Vaccines

Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh

(2010) Kazi Mizanur Rahman et al.   VACCINE

Development of prophylactic recombinant HPV58-attenuated Shigella live vector vaccine and evaluation of its protective efficacy and immunogenicity in the guinea pig keratoconjunctivitis model

(2009) W. Li et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Listeria monocytogenes Delivery of HPV-16 Major Capsid Protein L1 Induces Systemic and Mucosal Cell-Mediated CD4+ and CD8+ T-Cell Responses After Oral Immunization

(2009) Waleed Mustafa et al.   VIRAL IMMUNOLOGY